Dimerization of VEGF receptors and implications for signal transduction: a computational study.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biophysical Chemistry

• Publication date

  2007-03-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BPC.2007.03.010PMID 17442480PMCID PMC2711879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.

  2006cited by this paper
• Biology of vascular endothelial growth factors

  2006cited by this paper
• VEGF receptor signalling ? in control of vascular function

  2006cited by this paper
• Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.

  2006cited by this paper
• Angiogenesis in rheumatoid arthritis.

  2006cited by this paper
• Spatial modeling of dimerization reaction dynamics in the plasma membrane: Monte Carlo vs. continuum differential equations.

  2006cited by this paper
• Computational Model of Vascular Endothelial Growth Factor Spatial Distribution in Muscle and Pro-Angiogenic Cell Therapy

  2006cited by this paper
• A network model of early events in epidermal growth factor receptor signaling that accounts for combinatorial complexity.

  2006cited by this paper
• Monte Carlo simulations of VEGF binding to cell surface receptors in vitro.

  2005cited by this paper
• Computational Model of VEGF Spatial Distribution in Muscle and Pro-Angiogenic Cell Therapy

  2005cited by this paper
• Computational modeling reveals molecular details of epidermal growth factor binding

  2005cited by this paper
• Vascular Endothelial Growth Factor (VEGF)-A165-induced Prostacyclin Synthesis Requires the Activation of VEGF Receptor-1 and -2 Heterodimer*

  2005influential reference
• The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.

  2005cited by this paper
• Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model.

  2005influential reference
• Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.

  2004influential reference
• Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.

  2004cited by this paper
• The PDGF family: four gene products form five dimeric isoforms.

  2004cited by this paper
• A structure-based model for ligand binding and dimerization of EGF receptors.

  2004cited by this paper
• Heparan Sulfate Proteoglycans Function as Receptors for Fibroblast Growth Factor-2 Activation of Extracellular Signal–Regulated Kinases 1 and 2

  2004cited by this paper
• A Reaction-Diffusion Model of Basic Fibroblast Growth Factor Interactions with Cell Surface Receptors

  2004cited by this paper
• Mathematical Model of Human Growth Hormone (hGH)‐Stimulated Cell Proliferation Explains the Efficacy of hGH Variants as Receptor Agonists or Antagonists

  2004cited by this paper
• Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors

  2004cited by this paper
• Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding.

  2003cited by this paper
• Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites*

  2003cited by this paper
• Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

  2003influential reference
• Kinetic Analysis of Platelet-derived Growth Factor Receptor/Phosphoinositide 3-Kinase/Akt Signaling in Fibroblasts*

  2003cited by this paper
• Quantitative Analysis of HER2-mediated Effects on HER2 and Epidermal Growth Factor Receptor Endocytosis

  2003cited by this paper
• Characterization of the vascular endothelial growth factor-receptor interaction and determination of the recombinant protein by an optical receptor sensor.

  2002cited by this paper
• Single-chain Vascular Endothelial Growth Factor Variant with Antagonist Activity*

  2002influential reference
• Ligand-induced, receptor-mediated dimerization and activation of EGF receptor.

  2002cited by this paper
• Angiogenesis in rheumatoid arthritis

  2002cited by this paper
• 1H, 13C, and 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide.

  2002cited by this paper
• Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.

  2002influential reference
• Kinase Insert Domain Receptor (KDR) Extracellular Immunoglobulin-like Domains 4–7 Contain Structural Features That Block Receptor Dimerization and Vascular Endothelial Growth Factor-induced Signaling*

  2001cited by this paper
• Characterization of 123I‐vascular endothelial growth factor–binding sites expressed on human tumour cells: Possible implication for tumour scintigraphy

  2001influential reference
• Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121 *

  2001influential reference
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers.

  2001influential reference
• Receptor-selective Variants of Human Vascular Endothelial Growth Factor

  2000cited by this paper
• Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization

  1999cited by this paper
• Characterization of Vascular Endothelial Cell Growth Factor Interactions with the Kinase Insert Domain-containing Receptor Tyrosine Kinase

  1999cited by this paper
• Requirements for Binding and Signaling of the Kinase Domain Receptor for Vascular Endothelial Growth Factor*

  1998influential reference
• An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.

  1998influential reference
• Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor*

  1998cited by this paper
• Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance.

  1998cited by this paper
• The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.

  1997cited by this paper
• Calculation of diffusion-limited kinetics for the reactions in collision coupling and receptor cross-linking.

  1997cited by this paper
• Computer modelling of the receptor-binding domains of VEGF and PIGF.

  1997cited by this paper
• Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

  1997cited by this paper
• Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.

  1996influential reference
• The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*)

  1996cited by this paper
• Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors

  1996cited by this paper
• Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

  1996cited by this paper
• Comparative Analysis of Vascular Endothelial Growth Factor Receptors on Retinal and Aortic Vascular Endothelial Cells

  1995cited by this paper
• The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect.

  1994cited by this paper
• Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations.

  1994cited by this paper
• Specificity of vascular endothelial cell growth factor receptor ligand binding domains.

  1994cited by this paper
• Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

  1994cited by this paper
• Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media.

  1993cited by this paper
• Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.

  1993cited by this paper
• Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.

  1991cited by this paper
• Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

  1991cited by this paper
• Kinetic analysis of histamine release due to covalently linked IgE dimers.

  1982cited by this paper

• Impact of Endothelial Cell Repair Mechanisms on Doxorubicin-Induced Cardiomyopathy: Exploring Molecular Docking and Simulation of Angiogenic Factors

  2025cites this paper
• VEGF-B: A multifaceted modulator with emerging therapeutic applications.

  2025cites this paper
• Tyrosine Kinase Inhibitor Lenvatinib Based Nano Formulations and Cutting-Edge Scale-Up Technologies in revolutionizing Cancer Therapy.

  2025cites this paper
• The role of FGFR and VEGFR signaling pathways in the mechanisms of secondary resistance of gastrointestinal stromal tumors to tyrosine kinase receptor inhibitors

  2025cites this paper
• Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives

  2025cites this paper
• VEGF family in cortical development

  2025cites this paper
• The alveolus: Our current knowledge of how the gas exchange unit of the lung is constructed and repaired.

  2024cites this paper
• Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells

  2024influential citation
• Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways

  2024cites this paper
• The interplay between lymphatic vessels and macrophages in inflammation response

  2024cites this paper
• Multiscale computational model predicts how environmental changes and drug treatments affect microvascular remodeling in fibrotic disease

  2024cites this paper
• The metastatic cascade through the lens of therapeutic inhibition

  2024cites this paper
• Multiscale computational model predicts how environmental changes and treatments affect microvascular remodeling in fibrotic disease

  2024cites this paper
• Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression

  2024cites this paper
• A Review of Shrimp Cellular Receptors for WSSV: Potential Targets for Antiviral Strategies in Shrimp Aquaculture

  2023cites this paper
• Effects of the Foam Massage Roller on VEGF-A and FGF-2 Blood Levels in Young Men

  2023cites this paper
• Complement factor H inhibits endothelial cell migration through suppression of STAT3 signaling

  2023cites this paper
• Modeling the Cluster Size Distribution of Vascular Endothelial Growth Factor (VEGF) Receptors

  2022cites this paper
• The Chaperone System in Salivary Glands: Hsp90 Prospects for Differential Diagnosis and Treatment of Malignant Tumors

  2022cites this paper
• Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine

  2022cites this paper
• VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types

  2022cites this paper
• Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions.

  2022cites this paper
• Insights into the dynamics of ligand-induced dimerisation via mathematical modelling and analysis.

  2022cites this paper
• Mechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis

  2022cites this paper
• VEGFR1 signaling in retinal angiogenesis and microinflammation

  2021cites this paper
• Systems biology of angiogenesis signaling: Computational models and omics

  2021cites this paper
• Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone

  2021cites this paper
• Multistationarity in Cyclic Sequestration-Transmutation Networks

  2021influential citation
• The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy

  2021cites this paper
• Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment

  2021cites this paper
• Systems Biology Will Direct Vascular-Targeted Therapy for Obesity

  2020cites this paper
• Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy

  2020cites this paper
• VEGF-A splice variants bind VEGFRs with differential affinities

  2020cites this paper
• Calcium Signalling during Primary Angiogenic Sprouting in Zebrafish

  2020influential citation
• Origin of diverse phosphorylation patterns in the ERBB system

  2020cites this paper
• Neuroprotective and Neurestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases.

  2020cites this paper
• Binding and Structural Properties of DNA Aptamers with VEGF-A-Mimic Activity

  2020influential citation
• Mathematical Model Predicts Effective Strategies to Inhibit VEGF-eNOS Signaling

  2020cites this paper
• Modeling cell signaling in heterogeneous cancer environments

  2019cites this paper
• Mapping Tyrosine Kinase Receptor Dimerization to Receptor Expression and Ligand Affinities

  2019cites this paper
• A VEGF reaction-diffusion mechanism that selects variable densities of endothelial tip cells

  2019cites this paper
• Reducing Spatial Stochastic Models of Membrane Receptors to Approximately Equivalent Chemical Reaction Networks through Coarse Graining

  2019influential citation
• Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis

  2019cites this paper
• Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides.

  2018cites this paper
• Computer Simulation of TSP1 Inhibition of VEGF–Akt–eNOS: An Angiogenesis Triple Threat

  2018cites this paper
• Pathology of Tumor Angiogenesis

  2018cites this paper
• Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis

  2018cites this paper
• Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification

  2018cites this paper
• Polarised VEGFA Signalling at Vascular Blood–Neural Barriers

  2018cites this paper
• Ligand Binding Dynamics for Pre-dimerised G Protein-Coupled Receptor Homodimers: Linear Models and Analytical Solutions

  2018cites this paper
• Mathematical Modeling of Cellular Cross-Talk Between Endothelial and Tumor Cells Highlights Counterintuitive Effects of VEGF-Targeted Therapies

  2018cites this paper
• Quantifying the phosphorylation timescales of receptor–ligand complexes: a Markovian matrix-analytic approach

  2018cites this paper
• Pro-angiogenic therapeutics for preeclampsia

  2018cites this paper
• Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2

  2018cites this paper
• VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis.

  2018cites this paper
• VEGF Receptor Tyrosine Kinases: Key Regulators of Vascular Function.

  2017cites this paper
• Multi-physics interactions drive VEGFR2 relocation on endothelial cells

  2017cites this paper
• Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells

  2017cites this paper
• Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling.

  2017cites this paper
• Elastin‐like polypeptide switches: A design strategy to detect multimeric proteins

  2017cites this paper
• Mathematical Model for IL-6-Mediated Tumor Growth, and Targeted Treatment

  2017influential citation
• Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity.

  2017cites this paper
• Mathematical Modeling of Cellular Cross-Talk Between Endothelial and Tumor Cells Highlights Counterintuitive Effects of VEGF-Targeted Therapies

  2017influential citation
• Stochastic models of the binding kinetics of VEGF-A to VEGFR1 and VEGFR2 in endothelial cells

  2016influential citation
• Functionalization of Ultrabithorax Materials with Vascular Endothelial Growth Factor Enhances Angiogenic Activity.

  2016cites this paper
• Mechanisms and regulation of endothelial VEGF receptor signalling

  2016cites this paper
• Role of ubiquitin-modifying enzymes in regulating the endothelial response to VEGF-A

  2016cites this paper
• Predicting angiogenic receptor trafficking and signaling via computational systems biology

  2016cites this paper
• Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A

  2016cites this paper
• Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.

  2015cites this paper
• Quantum dot multiplexing for the profiling of cellular receptors.

  2015cites this paper
• The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis

  2015cites this paper
• Systems biology of the microvasculature.

  2015cites this paper
• SPARC Inhibits VEGF-mediated VEGFR2 Activation and Downstream Signaling

  2015cites this paper
• Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model

  2015cites this paper
• Adsorption and Release Behaviors of Vascular Endothelial Growth Factor on Porous Hydroxyapatite Ceramic Under Competitive Conditions

  2014cites this paper
• From Graph Coloring to Receptor Clustering

  2014influential citation
• Title Canonical and noncanonical vascular endothelial growth factor pathways : new developments in biology and signal transduction

  2014cites this paper
• Quantitative Characterization of Cellular Membrane-Receptor Heterogeneity through Statistical and Computational Modeling

  2014cites this paper
• Udział VEGF-A i jego receptorów w procesie angiogenezy

  2014cites this paper
• Receptor Pre-Clustering and T cell Responses: Insights into Molecular Mechanisms

  2014influential citation
• Correction: Quantitative Characterization of Cellular Membrane-Receptor Heterogeneity through Statistical and Computational Modeling

  2014cites this paper
• Differential Apicobasal VEGF Signaling at Vascular Blood-Neural Barriers

  2014cites this paper
• ATVB in Focus New Advancements on the Regulation of Angiogenesis

  2014cites this paper
• Endothelial Tip-Stalk Cell Pattern Formation As A Function Of Gene Regulatory Architecture

  2014influential citation
• Dimerization-based control of cooperativity.

  2014cites this paper
• Computational Systems Biology for the VEGF Family in Angiogenesis

  2014cites this paper
• Fluorescent resonance energy transfer imaging of VEGFR dimerization.

  2014cites this paper
• Processing of Vegf-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis

  2013cites this paper
• VEGF Signaling in Normal and Tumor Angiogenesis

  2013cites this paper
• Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

  2013cites this paper
• Роль рецепторов VEGF-A165 в ангиогенезе

  2013cites this paper
• A CONTINUOUS MODEL OF ANGIOGENESIS: INITIATION, EXTENSION, AND MATURATION OF NEW BLOOD VESSELS MODULATED BY VASCULAR ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETINS, PLATELET-DERIVED GROWTH FACTOR-B, AND PERICYTES

  2013cites this paper
• Both Kdr and Flt1 play a vital role in hypoxia‐induced Src‐PLD1‐PKCγ‐cPLA2 activation and retinal neovascularization

  2013cites this paper
• Analytical Solution of Steady-State Equations for Chemical Reaction Networks with Bilinear Rate Laws

  2013cites this paper
• The impact of high density receptor clusters on VEGF signaling

  2013influential citation
• Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation

  2013influential citation
• This is an Open Access article's PDF published in

  2012cites this paper
• Signal transduction by vascular endothelial growth factor receptors.

  2012cites this paper
• Computational models of VEGF-associated angiogenic processes in cancer.

  2012cites this paper